Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TOP2B | Q02880 | 1/20 | 0.70 |
| ▸ | MEN1 | O00255 | 7/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.66 |
| ▸ | BLM | P54132 | 5/20 | 0.66 |
| ▸ | LMNA | P02545 | 5/20 | 0.66 |
| ▸ | MAPK1 | P28482 | 5/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.66 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.66 |
| ▸ | NPC1 | O15118 | 3/20 | 0.66 |
| ▸ | RAB9A | P51151 | 3/20 | 0.66 |
| ▸ | RECQL | P46063 | 3/20 | 0.66 |
| ▸ | NSD2 | O96028 | 3/20 | 0.66 |
| ▸ | USP2 | O75604 | 2/20 | 0.66 |
| ▸ | TP53 | P04637 | 2/20 | 0.66 |
| ▸ | MTOR | P42345 | 2/20 | 0.66 |
| ▸ | EGFR | P00533 | 2/20 | 0.66 |
| ▸ | HTT | P42858 | 2/20 | 0.66 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.66 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.66 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1426702 | 0.92 | TOP2B (0.81) | TOP2BMEN1KMT2ABLMLMNA | |
| SCHEMBL29357976 | 0.92 | TOP2B (0.81) | TOP2BMEN1KMT2ABLMLMNA | |
| SCHEMBL18567079 | 0.91 | TOP2B (0.86) | TOP2BMEN1KMT2ABLMLMNA | |
| SCHEMBL6661577 | 0.91 | CYP19A1 (0.80) | TOP2BMEN1KMT2ABLMLMNA | |
| SCHEMBL6666259 | 0.90 | CYP19A1 (0.73) | TOP2BMEN1KMT2ABLMLMNA | |
| SCHEMBL20334357 | 0.89 | NQO1 (0.73) | TOP2BMEN1KMT2ABLMLMNA | |
| SCHEMBL497032 | 0.89 | MEN1 (0.81) | TOP2BMEN1KMT2ABLMLMNA | |
| SCHEMBL30439813 | 0.89 | MEN1 (0.81) | TOP2BMEN1KMT2ABLMLMNA | |
| Mitoxantrone SCHEMBL187688 | 0.87 | MEN1 (0.84) | TOP2BMEN1KMT2ABLMLMNA | |
| SCHEMBL8947726 | 0.87 | TOP2B (0.74) | TOP2BMEN1KMT2ABLMLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230240954-A1 | USE OF ANTHRAQUINONE DYES AND OF FLUORESCENT DYES FOR DYEING KERATIN FIBRES, DYEING PROCESS AND COMPOSITION | L'OREAL (FR) | 2023-08-03 | — | — | US | disclosed |
| US-20230240954-A1 | USE OF ANTHRAQUINONE DYES AND OF FLUORESCENT DYES FOR DYEING KERATIN FIBRES, DYEING PROCESS AND COMPOSITION | L'OREAL (FR) | 2023-08-03 | — | — | US | disclosed |
| EP-3558235-B1 | USE OF ANTHRAQUINONE DYES AND OF FLUORESCENT DYES FOR DYEING KERATIN FIBRES, DYEING PROCESS AND COMPOSITION | OREAL (FR) | 2021-09-08 | — | — | EP | disclosed |
| WO-2018115337-A1 | USE OF ANTHRAQUINONE DYES AND OF FLUORESCENT DYES FOR DYEING KERATIN FIBRES, DYEING PROCESS AND COMPOSITION | L'OREAL (FR) | 2018-06-28 | — | — | WO | disclosed |
| US-5942292-A | Spacer for liquid crystal display and liquid crystal display made by using the same | KAO CORPORATION (JP) | 1999-08-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230240954-A1 | USE OF ANTHRAQUINONE DYES AND OF FLUORESCENT DYES FOR DYEING KERATIN FIBRES, DYEING PROCESS AND COMPOSITION | KRT18, CUTA, KLK5 | TOP2B 989/4885MEN1 2794/4885KMT2A 2181/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.